Hysteroscopic permanent tubal sterilization using a nitinol-dacron intratubal device without anaesthesia in the outpatient setting: procedure feasibility and effectiveness
Authors:
- E. CosmiECE. Cosmi
- G. SaccoGSG. Sacco
- C. SaccardiCSC. Saccardi
- A. CiavattiniACA. Ciavattini
- G. AmbrosiniGAG. Ambrosini
Open Access
- 5 August 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 20 (12) , 3419-3422
Abstract
BACKGROUND: Hysteroscopic permanent tubal sterilization has recently been introduced, resulting in a non-invasive, safe and effective technique. The aim of this study was to assess the feasibility of outpatient hysteroscopic tubal sterilization using a nitinol-dacron intratubal device without anaesthesia and to assess patient procedure compliance. MATERIALS AND METHODS: We untertook a prospective study of 36 consecutive cases of outpatient hysteroscopic tubal sterilization using a nitinol-dacron intratubal device without anaesthesia. Tubal sterilization was performed by placing the device with the aid of a 5.2-mm continuous-flow operative hysteroscope. At the end of the procedure women were asked to rate the pain experienced on a visual analogue scale (VAS) (0, no discomfort to 100, severe discomfort). Successful device placement was assessed after 3 months by hysterosalpingography and diagnostic hysteroscopy. RESULTS: Successful bilateral placement was obtained in 32 patients (88.9%); in one (2.8%) the placement was monolateral; and in three (8.3%) the procedure failed. Mean operating time was 8.6 ± 5.3 min. A mean VAS of 36.1 ± 23.9 was recorded. CONCLUSIONS: The nitinol-dacron intratubal device is safe, appears to be effective long-term, is non-invasive and can be used in the outpatient setting without anaesthesia. Low-level discomfort was experienced by the patients. Limitations of its use include that it is not effective immediately, it is irreversible, it requires special equipment and training, and it is difficult to use in cases of uterine anomalies. We conclude that this method may be offered to all woman asking for permanent tubal sterilization, particularly those who refuse or have contraindications for anaesthesia.Keywords
This publication has 17 references indexed in Scilit:
- Essure Hysteroscopic Sterilization: Results Based on Utilizing a New Coil Catheter Delivery SystemThe Journal of the American Association of Gynecologic Laparoscopists, 2004
- Essure®: a new device for hysteroscopic tubal sterilization in an outpatient settingFertility and Sterility, 2004
- Une nouvelle technique de stérilisation tubaire sous contrôle hystéroscopique: À propos de 45 observationsJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2004
- Learning curve for hysteroscopic sterilisation: Lessons from the first 80 casesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2004
- Randomised comparison of distension media for outpatient hysteroscopyBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- Ultrasound detection of the Essure permanent birth control device: A case seriesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2003
- Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II studyHuman Reproduction, 2003
- The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first EssureTM pbc clinical studyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2001
- Complications of Interval Laparoscopic Tubal SterilizationObstetrics & Gynecology, 2000
- The risk of pregnancy after tubal sterilization: Findings from the U.S. Collaborative Review of SterilizationAmerican Journal of Obstetrics and Gynecology, 1996